Antibiotic Prophylaxis in Open-Heart Surgery:
|
|
- Kathlyn Caldwell
- 6 years ago
- Views:
Transcription
1 Antibiotic Prophylaxis in Open-Heart Surgery: A Comparison of Cefamandole, Cefuroxime, and Cefazolin Layne. Gentry, M.D., Barry J. Zeluff, M.D., and Denton A. Cooley, M.D. ABSTRACT We undertook a prospective randomized evaluation of cefamandole nafate, cefuroxime sodium, and cefazolin sodium as prophylaxis in open-heart operations. A total of 93 patients having an elective procedure were enrolled in the study, and 62 of them were eventually considered evaluable. There were no significant differences between the three study groups. The overall rate of infection and the rate of infection according to demographic variables was not significantly different between the three antibiotics. Serious complications and deaths were also similar between the three agents. The presence of multiple severe underlying conditions was a risk factor for infection, independent of the antibiotic used. We conclude that there are no differences in the efficacies of the three agents in preventing postoperative infections in patients having open-heart operation. Cefuroxime, principally because of its every-12-hour dose, is far less expensive than cefamandole or cefazolin. Antibiotic prophylaxis in open-heart surgery was used for one of the first times in 1963 [l], in an effort to prevent an unacceptably high incidence of prosthetic heart valve endocarditis, later documented in 1965 [2]. Initially, penicillin and streptomycin were used to combat gram-positive skin flora, especially Staphylococcus aureus and S. epidermidis, opportunistic to patients undergoing sternotomy. Between 1964 and 1977, much folklore was accumulated regarding the use of antibiotics in preventing infections. In particular, the benefit of prophylaxis for patients undergoing aorta-coronary artery bypass procedures was still unclear in In 1979, using rigid criteria for an evaluable study of prophylaxis [3], a prospective double-blind drug-versusplacebo trial proved that preoperative treatment with methicillin sodium prevented infections in patients undergoing aorta-coronary artery bypass procedures [4]; in fact, none of the methicillin-treated patients had a postoperative infection, while 21% of the patients who received the placebo did. There have been reports of low-risk open-heart operations without antibiotic prophylaxis [5]. However, these procedures utilized continuous intrapericardial lavage with an antibiotic-laden irrigant. Although we prefer intravenous administration because of the improved dosage accuracy, continuous From the Infectious Diseases Section, St. Luke s Episcopal Hospital, and the Texas Heart Institute, Houston, TX. Accepted for publication Jan 22, 1988 Address reprint requests to Dr. Layne Gentry, St. Luke s Episcopal Hospital, 672 Bertner 2-233, Houston, TX 773. antibiotic irrigation has been shown to result in adequate serum levels for prophylaxis [6]. In 1985, another drug-versus-placebo trial was reported [7]. This trial was discontinued because of a 24% rate of infection in the placebo group. Perhaps investigators now realize that the need for antibiotic prophylaxis in open-heart surgery is clearly established. Drug treatment and selection have been extensively examined. In 1961, it was demonstrated that preoperative dosing would be required for prophylaxis [8]. Studies published in 1972 indicated that prophylactic antibiotic treatment past the fourth postoperative day would be unnecessary [9]. As for the selection of antimicrobials, it was believed that a penicillin in combination with an aminoglycoside would provide adequate protection. In 1973, it was shown that targeted prevention of gram-positive infections might lead to a significant increase in the incidence of gram-negative infections because of the lack of activity of the antibiotic against gram-negative pathogens [lo]. The cephalosporins, with in vitro activity against both gram-positive and gram-negative organisms, penetration into heart muscle, and low toxicity, were obvious choices for prophylaxis [ll]. At our institution, cephalothin sodium, 1. gm 3 minutes preoperatively and every 6 hours for five postoperative days, was used as antibiotic prophylaxis in open-heart operations from 1964 to 1976, when we switched to cefamandole nafate, at the same dose, because of the enhanced in vitro activity of cefamandole against many pathogens [12]. In 1985, after preliminary reports that cefuroxime sodium and cefazolin sodium demonstrated in vivo activity comparable to that of cefamandole and at a much reduced cost [13], we prospectively evaluated these three drugs in a randomized study. Material and Methods Between 1985 and 1987, all patients undergoing elective open-heart operations were considered for the study. By elective, we mean that the patient was admitted to the hospital for an open-heart procedure. Patients were excluded from the study if they were less than 18 years old, allergic to penicillin, or experiencing an infection that might require concurrent antimicrobial therapy. A total of 93 patients were initially entered into the study. Those patients who were included in the study received cefamandole nafate (Mandol; Eli Lilly and Company), cefuroxime sodium (Zinacef; Glaxo Inc.), or cefazolin sodium (Kefzol; Eli Lilly and Company) in a random manner according to the month of operation. 167 Ann Thorac Surg , Aug Copyright 1988 by The Society of Thoracic Surgeons
2 168 The Annals of Thoracic Surgery Vol 46 No 2 August 1988 All surgical procedures were performed by the same surgical team at the Texas Heart Institute, and inpatient care was in the postoperative recovery unit, intensive care centers, and inpatient rooms at St. Luke's Episcopal Hospital. The study protocol, approved by the institutional review board at St. Luke's Hospital, called for intravenous antibiotic administration 3 minutes prior to operation and at regular intervals for 48 hours after the procedure. The schedule for cefamandole was 2. gm preoperatively and every 6 hours postoperatively; for cefuroxime, 1.5 gm preoperatively and every 12 hours postoperatively; and for cefazolin, 2. gm preoperatively and every 8 hours postoperatively. Doses were increased to elevate serum levels to the mean inhibitory concentration (MIC) of staphylococci isolated in our institution. In 1984, the 48-hour MIC9 of S. aureus was 16 pg/ml for cefamandole, 16 pg/ml for cefuroxime, and 32 pg/ml for cefazolin, and the 48-hour MIC9 of S. epidermidis was 16 pg/ml for cefamandole, 32 pg/ml for cefuroxime, and 32 pg/ml for cefazolin. Intraoperative serum levels of antibiotics were randomly measured, and laboratory data were used to monitor postoperative liver and kidney function. A complete review of medical records assured compliance with the protocol. An "infection" was defined as clinical signs and symptoms of infection, with confirmation by the isolation in culture of a potential pathogen. Each infection was classified as "surgery related' or "nosocomial," according to the site and the pathogen isolated. Surgeryrelated infections were wound infections, endocarditis, or catheter-associated bacteremias; nosocomial infections were urinary tract infections or respiratory infections. An "infectious death" was defined as a death due in part to a culture-proven infection. A total of 283 patients entered into the study were later deemed inevaluable. Recognizing that length of preoperative stay is a significant risk factor for gram-negative nosocomial infectious complications, we excluded 159 patients whose operation occurred more than 6 hours after admission. Others excluded were 77 patients who received other antimicrobials concurrent with the prophylaxis regimen, 31 patients for whom the prophylaxis regimen was erroneously extended by one or two doses, and 16 patients for whom the prophylaxis was prematurely discontinued because of evidence of liver or kidney failure. The study concluded with a total of 62 evaluable patients-more than 2 evaluable patients for each of the three antibiotics. Although it would have been necessary to evaluate more than twice this many patients to rule out significant type I1 error for infection rates less than 5%, a study that large was beyond our practical ability to perform. Results Shown in Table 1 are the patient populations and antibiotic levels for the three study groups. Using a chi-square test of statistical significance, there were no significant differences in patient demographics, predisposing diagnosis, or procedures between the three groups (p >.5). Because of a concurrent study that would later validate the 2.-gm dose of cefamandole [14], more of the cefamandole patients were treated in A "predisposing diagnosis" was defined as the presence of multiple severe underlying conditions, such as diabetes mellitus, myocardial infarction, congestive heart failure, or immunodeficiency. The intraoperative serum antibiotic concentration levels verified that the preoperative dose of each drug was appropriately administered, and the levels we measured were compatible with the serum half-lives of the three antibiotics. Detailed in Table 2 are the infectious complications. Of the 62 patients, a postoperative infection developed in 45 (7%). By classification, 22 infections were surgery related and 23, nosocomial. Of the 22 surgery-related infections, there were 13 wound infections, 2 instances of endocarditis, and 7 instances of bacteremia. Using another chi-square test, there were no differences in the overall infection rates between patients with cefamandole, cefuroxime, or cefazolin. Also, there were no differences between the three groups in the rates of surgery-related or nosocomial infections, or in the types of pathogens isolated. In other words, no data were collected to indicate any significant difference in the prophylactic benefits of the three agents. There were no adverse reactions to the antibiotics requiring a discontinuation of the regimen, and there were no deaths directly related to the operation. The 2 deaths in the cefamandole patients occurred in 1985, and were due to nosocomial infections caused by Pseudomonus aeruginosa and Citrobacter diversus. The 1 death among the cefazolin patients occurred in 1986, and was due to a nosocomial infection caused by Citrobacter diversus. Despite in vitro sensitivity data to the contrary, none of the three drugs appeared clinically active against methicillin-resistant S. epidermidis, a pathogen of increasing concern in our institution. We also estimated the average increase in the length of stay in the hospital attributable to a postoperative infection, and found that a postoperative infection adds, on average, five days to the patient's stay. Presented in Table 3 are the rates of infection by age, sex, weight, diagnosis, procedure, and pump time. There were no significant differences in the infection rates between the three agents for any of the variables listed (p >.5). However, the rates for those patients more than 6 years old or for those on bypass for longer than 6 minutes were markedly elevated. With repetitive univariate analysis, the only significant risk factor, independent of prophylaxis, for our patients was the diagnosis of multiple severe underlying conditions. Shown in Table 4 are the costs of administering the drugs according to the approved protocol, the average
3 169 Gentry et al: Antibiotic Prophylaxis Comparison Table 1. Populatiolr Profiles and Antibiotic Levelsa Variable Cefamandole Cefuroxime (N = 217) (N = 23) Cefazolin (N = 2) Overall (N = 62) Age (yr) >6 <6 Sex Male Female Weight (kg) >SO <SO Diagnosis >I uc <1 uc Procedure ACAB Valve Both Other Pump time (min) >6 <6 Dosage Serum levels (kg/ml) 118 (54) 99 (46) 175 (81) 42 (19) 11 (51) 17 (49) 86 (4) 131 (6) 17 (78) 25 (12) 9 (4) 13 (6) 27 (12) 19 (88) 2. gm q. 6h (47) 18 (53) 151 (74) 52 (26) 96 (47) 17 (53) 1 (49) 13 (51) 161 (79) 25 (12) 11 (5) 6 (3) 79 (39) 124 (61) 1.5 gm q. 12h (77) 46 (23) 17 (53.5) 93 (46.5) 99 (49.5) 11 (5.5) 149 (74.5) 29 (14.5) 11 (5.5) 11 (5.5) 2. gm q. 8h (51) 37 (5) 48 (77) 14 (23) 313 (51) 37 (5) 285 (46) 335 (54) 48 (77) 79 (13) 31 (5) 3 (5) 26 (33) 414 (67) NA NA "Numbers in parentheses are percentages. UC = severe underlying condition, such as diabetes mellitus, myocardial infarction, or congestive heart failure; ACAB = aorta-coronary artery bypass; NA = not applicable. Table 2. Infectious Complications" Variable (N = 217) (N = 23) (N = 2) (N = 62) All infections 16 (7) 14 (7) 15 (7.5) 45 (7) Operation relatedb 8 (4) 6 (3) 8 (4) 22 (4) Staphylococcus species 5 (2) 4 (2) 7 (3.5) 16 (3) Pseudomonas species 2 (.9) l(.5) 3 (.5) Enterobucter species Citrobacter species l(.5) 1 (.5) 1 (.5) 2 (.3) 1 (.2) Nosocomiap 8 (4) 8 (4) 7 (3.5) 23 (4) Escherichia species 3 (1) 3 (2) l(.5) 7 (1) Klebsiella species 4 (2) l(.5) 5 (.8) Enterococci 3 (1) 2 (1) 5 (.8) Pseudomonas species l(.5) l(.5) 2 (1) 4 (.6) Citrobacter species l(.5) l(.2) Proteus species 1 (.5) 1 (.2) Infectious deaths 2 (Ps, C) 1 (C) 3 (.5) Increase in LOS (d) "Numbers in parentheses are percentages. bthirteen had wound infection, 2 had endocarditis, and 7 had bacteremia 'These were urinary tract or respiratory infections. LOS = length of stay (estimated average increase in length of stay because of a postoperative infection); Ps = Pseudomonus; C = Citrobucter.
4 17 The Annals of Thoracic Surgery Vol 46 No 2 August 1988 Table 3. Infection Rates and Risk Factorsa Variable (N = 217) (N = 23) (N = 2) (N = 62) Age (yr) >6 9 (4, 5) 1 (5, 5) 12 (7, 5) 1 (5, 5) < 6 4 (3, 1) 4 (1, 3) 3 (1, 2) 4 (2, 2) Sex Male 7 (4, 3) 6 (3, 3) 2 (1, 1) 5 (3, 2) Female 9 (2, 7) 1 (4, 6) 6 (4, 2) 8 (3, 5) Weight (kg) > 8 9 (5, 4) 5 (3, 2) 7 (3, 4) 7 (4, 3) < 8 6 (2, 4) 9 (3, 6) 8 (5, 3) 8 (3, 5) Diagnosis >1 UCb 11 (6, 5) 12 (5, 7) 14 (7, 7) 12 (6, 6) <1 uc 5 (2, 3) 2 (1, 1) 1 (1, ) 2 (1, 1) Procedure ACAB 7 (4, 3) 6 (3, 3) 8 (5, 3) 7 (4, 3) Valve 16 (4, 12) 6 (3, 3) 7 (2, 5) Both 36 (9, 27) 9 (, 9) 15 (3, 12) Other 9 (, 9) 3 (, 3) Pump time (min) > 6 15 (4, 11) 1 (4, 6) 8 (4, 4) 11 (4, 7) < 6 7 (4, 3) 4 (2, 2) 7 (4, 3) 6 (3, 3) All data are shown as percentages. The first number is the total percentage in the specific subcategory; the two numbers in parentheses are the percentage with an operation-related infection and a nosocomial infection, in that order. bthis was a significant risk factor. UC = severe underlying condition; ACAB = aorta-coronary artery bypass. Table 4. Economic Considerations Variable (N = 217) (N = 23) (N = 2) (N = 62) Treatment 2. gm, 9 doses 1.5 gm, 5 doses 2. gm, 7 doses NA Cost of drug (incl. admin.) $29 $145 $225 $222 Infection rate wio drug (%) Increase in LOS (per patient) (d)b Cost of care (per patienty $5 $5 $5 $5 Cost savings (per patient) $21 $355 $275 $278 This is based on the minimum estimated infection rate last reported without prophylaxis [5]. bthis is the average estimated increase in LOS because of postoperative infection. The average for the entire study group was 5 days. This is based on the minimum estimated daily charge at our institution of $5 per day. NA = not applicable; LOS = length of stay. increased length of hospital stay associated with a postoperative infection, and the computed economic impact of antibiotic prophylaxis. At our institution, antibiotic prophylaxis for open-heart procedures is not only clinically mandated, but cost-effective as well. Comment The scientific evidence clearly indicates that open-heart operations without antibiotic prophylaxis would be ill advised. Our data reveal no significant differences in the efficacies of cefamandole, cefuroxime, and cefazolin in the prevention of postoperative infections for patients having an open-heart procedure. This conclusion essentially substantiates recent observations of other investigators [15,16]. While our research was unable to rule out type I1 error, our data nonetheless contribute to the conclusion that there is no in vivo evidence whatsoever that any of the three drugs offers markedly superior performance as antibiotic prophylaxis in open-heart surgery * Since cefamandole, cefuroxime, and cefazolin are equally safe and effective, the surgeon, in committee with the infectious disease consultant and the pharmacist, may make a decision on which antibiotic prophylaxis to use based on economic considerations. At our
5 171 Gentry et a1 Antibiotic Prophylaxis Comparison institution, we now use cefuroxime as the antibiotic prophylaxis of choice in open-heart surgery. Future Requirements Each year in our institution, more than 1,2 organisms are isolated from more than 1, blood cultures, and of these organisms, 28% are S. epidermidis. Between 1985 and 1987, our surveillance of the susceptibility of pathogens revealed that the percentage of isolates of s. epidermidis resistant to methicillin rose from 16 to 61% in our institution. It is now apparent that any new agents to be evaluated for prophylactic use must show enhanced activity against this troublesome organism, to improve on the performance of the cephalosporins. Vancomycin is the current drug of choice against methicillin-resistant staphylococci, yet it is hoped that newer broad-spectrum, less-toxic antimicrobials will provide increased protection to the patient undergoing an openheart operation. This research was supported by grants from Eli Lilly and Company, Indianapolis, IN, and Glaxo Inc., Research Triangle Park, NC. We thank Clayton Vernon for the preparation of the manuscript. References Slonim R, Litwak RS, Gadboys HL, Ehrenkranz NJ: Antibiotic prophylaxis of infections complicating open-heart operations. Antimicrob Agents Chemother 3:731, 1963 Herr R, Starr A, McCord CW, Wood JA: Special problems following valve replacement. Ann Thorac Surg 1:43, 1965 Chodak GW, Plaut ME: Use of systemic antibiotics for prophylaxis in surgery. Arch Surg 112:326, Fong IW, Baker CB, McKee DC: The value of prophylactic antibiotics in aorta-coronary bypass operations. J Thorac Cardiovasc Surg 78:98, 1979 Sutherland RD, Martinez HE, Guynes WA: Antibiotics and coronary artery bypass operations: an 11-year experience. Infect Surg 4:585, 1985 Raine PA, Courtis GR, Fowler R, et al: The intraperitoneal use of cefazolin. J Surg Res 25232, 1978 Penketh AR, Wansbrough-Jones MH, Wright E, et al: Antibiotic prophylaxis for coronary artery bypass graft surgery. Lancet 1:15, 1985 Burke JF: The effective period of preventive antibiotic action in experimental incisions and dermal lesions. Surgery 1:161, 1961 Conte JE, Cohen SN, Roe BB, Elashoff RM: Antibiotic prophylaxis and cardiac surgery. Ann Intern Med 76:943, 1972 Slaughter L, Morris JE, Starr A A prosthetic valvular endocarditis. Circulation 47:1319, 1973 Quintilliani R, Klimek JJ, Nightingale C: The penetration characteristics of cephapirin and cephalothin into the right atrial appendage and pericardial fluid in patients undergoing open-heart surgery. J Infect Dis 139:348, 1979 Griffith RS, Black HR, Brier GL, Walny JD: Cefamandole in vitro and clinical pharmacokinetics. Antimicrob Agents Chemother 1:814, 1976 Bain WH, Nasr A, Towler C: Use of cefuroxime sodium as a prophylactic antibiotic in patients undergoing coronary artery bypass surgery. In Wood C, Rue Y (eds): Cefuroxime Update. Royal Society of Medicine International Congress and Symposium Series No. 38. London, Academic, 1981 Gentry LO, Zeluff BJ: Cefamandole prophylaxis for cardiovascular surgery: a dosage comparison. Tex Heart Inst J 14: 374, 1987 Slama TG, Sklar SJ, Misinski J, Fess SW: Randomized comparison of cefamandole, cefazolin and cefuroxime prophylaxis in open-heart surgery. Antimicrob Agents Chemother 29:744, 1986 Peterson CD, Lake KD, Arom KV, Love KR. Antibiotic prophylaxis in open-heart surgery patients: comparison of cefamandole and cefuroxime. Drug Intelligence Clin Pharm 21:728, 1987
Antibiotic prophylaxis in cardiothoracic surgery in
Thorax 1986;41:396-400 Antibiotic prophylaxis in cardiothoracic surgery in the United Kingdom: current practice APR WILSON, T TREASURE, MF STURRIDGE, RN GRONEBERG From the Department of Cardiothoracic
More informationProphylactic antibiotic timing and dosage. Dr. Sanjeev Singh AIMS, Kochi
Prophylactic antibiotic timing and dosage Dr. Sanjeev Singh AIMS, Kochi Meaning - Webster Medical Definition of prophylaxis plural pro phy lax es \-ˈlak-ˌsēz\play : measures designed to preserve health
More informationAntibiotic Prophylaxis Update
Antibiotic Prophylaxis Update Choosing Surgical Antimicrobial Prophylaxis Peri-Procedural Administration Surgical Prophylaxis and AMS at Epworth HealthCare Mr Glenn Valoppi Dr Trisha Peel Dr Joseph Doyle
More informationAntimicrobial prophylaxis. Bs Lưu Hồ Thanh Lâm Bv Nhi Đồng 2
Antimicrobial prophylaxis Bs Lưu Hồ Thanh Lâm Bv Nhi Đồng 2 Definition The United States Centers for Disease Control and Prevention (CDC) has developed criteria that define surgical site infection (SSI)
More informationSimilar to Penicillins: -Chemically. -Mechanism of action. -Toxicity.
Similar to Penicillins: -Chemically. -Mechanism of action. -Toxicity. Cephalosporins are divided into Generations: -First generation have better activity against gram positive organisms. -Later compounds
More informationThe CARI Guidelines Caring for Australians with Renal Impairment. 8. Prophylactic antibiotics for insertion of peritoneal dialysis catheter
8. Prophylactic antibiotics for insertion of peritoneal dialysis catheter Date written: February 2003 Final submission: May 2004 Guidelines (Include recommendations based on level I or II evidence) Antibiotic
More informationSurgical prophylaxis for Gram +ve & Gram ve infection
Surgical prophylaxis for Gram +ve & Gram ve infection Professor Mark Wilcox Clinical l Director of Microbiology & Pathology Leeds Teaching Hospitals & University of Leeds, UK Heath Protection Agency Surveillance
More informationPrevention of Perioperative Surgical Infections
Prevention of Perioperative Surgical Infections Michael A. West, MD, PhD, FACS Department of Surgery University California San Francisco San Francisco, CA, USA Surgical Site Infections (SSI) 2-5% of operated
More informationSee Important Reminder at the end of this policy for important regulatory and legal information.
Clinical Policy: Reference Number: CP.HNMC.04 Effective Date: 07.01.17 Last Review Date: 02.18 Line of Business: Medicaid - HNMC Revision Log See Important Reminder at the end of this policy for important
More informationGynaecological Surgery in Adults Surgical Antibiotic Prophylaxis
Gynaecological Surgery in Adults Surgical Antibiotic Prophylaxis Full Title of Guideline: Author (include email and role): Division & Speciality: Scope (Target audience, state if Trust wide): Review date
More informationGeneral Approach to Infectious Diseases
General Approach to Infectious Diseases 2 The pharmacotherapy of infectious diseases is unique. To treat most diseases with drugs, we give drugs that have some desired pharmacologic action at some receptor
More informationSupplementary Appendix
Supplementary Appendix This appendix has been provided by the authors to give readers additional information about their work. Supplement to: Bennett-Guerrero E, Pappas TN, Koltun WA, et al. Gentamicin
More informationOther Beta - lactam Antibiotics
Other Beta - lactam Antibiotics Assistant Professor Dr. Naza M. Ali Lec 5 8 Nov 2017 Lecture outlines Other beta lactam antibiotics Other inhibitors of cell wall synthesis Other beta-lactam Antibiotics
More informationThe Effect of Perioperative Use of Prophylactic Antibiotics on Surgical Wound Infection
THE IRAQI POSTGRADUATE MEDICAL JOURNAL PROPHYLACTIC ANTIBIOTICS ON SURGICAL WOUND INFECTION The Effect of Perioperative Use of Prophylactic Antibiotics on Surgical Wound Infection Ahmed Hamid Jasim*, Nabeel
More informationSystemic Antimicrobial Prophylaxis Issues
Systemic Antimicrobial Prophylaxis Issues Pierre Moine Department of Anesthesiology University of Colorado Denver 3 rd International Conference on Surgery and Anesthesia OMICs Group Conference The Surgical
More informationNQF-ENDORSED VOLUNTARY CONSENSUS STANDARDS FOR HOSPITAL CARE. Measure Information Form Collected For: CMS Voluntary Only
Last Updated: Version 4.4a NQF-ENORSE VOLUNTARY CONSENSUS STANARS FOR HOSPITAL CARE Measure Information Form Collected For: CMS Voluntary Only Measure Set: Surgical Care Improvement Project (SCIP) Set
More informationAntimicrobial Prophylaxis in Digestive Surgery
Antimicrobial Prophylaxis in Digestive Surgery Toar JM. Lalisang, MD, PhD Digestive Surgery Division Cipto Mangunkusumo Hospital Medical Faculty Universitas Indonesia Antibiotic must be present before
More informationDeveloped by Kathy Wonderly RN, MSEd,CPHQ Developed: October 2009 Most recently updated: December 2014
Developed by Kathy Wonderly RN, MSEd,CPHQ Developed: October 2009 Most recently updated: December 2014 The Center for Medicare and Medicaid (CMS) is moving away from collecting data on the process of care
More informationPost-operative surgical wound infection
Med. J. Malaysia Vol. 45 No. 4 December 1990 Post-operative surgical wound infection Yasmin Abu Hanifah, MBBS, MSc. (London) Lecturer Department of Medical Microbiology, Faculty of Medicine, University
More informationA Study on Pattern of Using Prophylactic Antibiotics in Caesarean Section
IOSR Journal Of Pharmacy (e)-issn: 2250-3013, (p)-issn: 2319-4219 www.iosrphr.org Volume 5, Issue 1 (January 2015), PP. -12-18 A Study on Pattern of Using Prophylactic Antibiotics in Caesarean Section
More informationInappropriate Use of Antibiotics and Clostridium difficile Infection. Jocelyn Srigley, MD, FRCPC November 1, 2012
Inappropriate Use of Antibiotics and Clostridium difficile Infection Jocelyn Srigley, MD, FRCPC November 1, 2012 Financial Disclosures } No conflicts of interest } The study was supported by a Hamilton
More informationAntimicrobial Prophylaxis in the Surgical Patient. M. J. Osgood
Antimicrobial Prophylaxis in the Surgical Patient M. J. Osgood Outline Definitions surgical site infection (SSI) Risk factors Wound classification Microbiology of SSIs Strategies for prevention of SSIs
More informationCefuroxime 1.5gm IV and Metronidazole 500mg IV. Metronidazole 500mg IV/Ampicillin-sulbactam e 3g/Ceftriaxone 2gm. +Metronidazole 500mg/Ertapenem 1gm
SURGICAL ANTIBIOTIC PROPHYLAXIS GENERAL SURGERY* PROCEDURE RECOMMENDED AGENTS a,b Clean None None ALTERNATIVE AGENTS (If allergic to penicillin or colonized/infected with MRSA at any site) Clean with potential
More informationAerobic bacterial infections in a burns unit of Sassoon General Hospital, Pune
Original article Aerobic bacterial infections in a burns unit of Sassoon General Hospital, Pune Patil P, Joshi S, Bharadwaj R. Department of Microbiology, B.J. Medical College, Pune, India. Corresponding
More informationAntimicrobial Selection and Therapy for Equine Musculoskeletal Trauma
Antimicrobial Selection and Therapy for Equine Musculoskeletal Trauma Lucio Petrizzi DVM DECVS Università degli Studi di Teramo Surgical site infections (SSI) Microbial contamination unavoidable Infection
More informationAntibiotic Prophylaxis in Spinal Surgery Antibiotic Guidelines. Contents
Antibiotic Prophylaxis in Spinal Antibiotic Guidelines Classification: Clinical Guideline Lead Author: Antibiotic Steering Committee Additional author(s): Authors Division: DCSS & Tertiary Medicine Unique
More informationThe Impact of meca Gene Testing and Infectious Diseases Pharmacists. Intervention on the Time to Optimal Antimicrobial Therapy for ACCEPTED
JCM Accepts, published online ahead of print on 7 May 2008 J. Clin. Microbiol. doi:10.1128/jcm.00801-08 Copyright 2008, American Society for Microbiology and/or the Listed Authors/Institutions. All Rights
More informationAppropriate antimicrobial therapy in HAP: What does this mean?
Appropriate antimicrobial therapy in HAP: What does this mean? Jaehee Lee, M.D. Kyungpook National University Hospital, Korea KNUH since 1907 Presentation outline Empiric antimicrobial choice: right spectrum,
More informationSurgery And Cephalosporins: A Marriage Made In Heaven Or Time For Divorce?
ISPUB.COM The Internet Journal of Surgery Volume 8 Number 1 Surgery And Cephalosporins: A Marriage Made In Heaven Or Time For Divorce? M Morgan Citation M Morgan.. The Internet Journal of Surgery. 2005
More informationAntibiotic prophylaxis guideline for colorectal, hepatobiliary and vascular surgery for adult patients.
Antibiotic prophylaxis guideline for colorectal, hepatobiliary and vascular surgery for adult patients. Full Title of Guideline: Author (include email and role): Division & Speciality: Scope (Target audience,
More information2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY. MEASURE TYPE: Process
Quality ID #407: Appropriate Treatment of Methicillin-Susceptible Staphylococcus Aureus (MSSA) Bacteremia National Quality Strategy Domain: Effective Clinical Care 2018 OPTIONS FOR INDIVIDUAL MEASURES:
More informationCost high. acceptable. worst. best. acceptable. Cost low
Key words I Effect low worst acceptable Cost high Cost low acceptable best Effect high Fig. 1. Cost-Effectiveness. The best case is low cost and high efficacy. The acceptable cases are low cost and efficacy
More informationDuring the second half of the 19th century many operations were developed after anesthesia
Continuing Education Column Surgical Site Infection and Surveillance Tae Jin Lim, MD Department of Surgery, Keimyung University College of Medicine E mail : tjlim@dsmc.or.kr J Korean Med Assoc 2007; 50(10):
More informationGUIDELINES FOR THE MANAGEMENT OF COMMUNITY-ACQUIRED PNEUMONIA IN ADULTS
Version 3.1 GUIDELINES FOR THE MANAGEMENT OF COMMUNITY-ACQUIRED PNEUMONIA IN ADULTS Date ratified June 2008 Updated March 2009 Review date June 2010 Ratified by Authors Consultation Evidence base Changes
More informationANTIBIOTICS USED FOR RESISTACE BACTERIA. 1. Vancomicin
ANTIBIOTICS USED FOR RESISTACE BACTERIA 1. Vancomicin Vancomycin is used to treat infections caused by bacteria. It belongs to the family of medicines called antibiotics. Vancomycin works by killing bacteria
More informationVCH PHC SURGICAL PROPHYLAXIS RECOMMENDATIONS
VCH PHC SURGICAL PROPHYLAXIS RECOMMENDATIONS CARDIAC Staphylococcus aureus, S. epidermidis, except for For patients with known MRSA colonization, recommend decolonization with Antimicrobial Photodynamic
More informationJerome J Schentag, Pharm D
Clinical Pharmacy and Optimization of Antibiotic Usage: How to Use what you have Learned in Pharmacokinetics and Pharmacodynamics of Antibiotics Jerome J Schentag, Pharm D Presented at UCL on Thursday
More informationSuper Bugs and Wonder Drugs: Protecting the One While Respecting the Many
Super Bugs and Wonder Drugs: Protecting the One While Respecting the Many Vicki Stringfellow, MSN, CPNP-AC/PC Werner Division of Pediatric Critical Care University of Kentucky Lexington, KY Disclosure
More informationResponsible use of antibiotics
Responsible use of antibiotics Uga Dumpis MD, PhD Department of Infectious Diseases and Infection Control Pauls Stradiņs Clinical University Hospital Challenges in the hospitals Antibiotics are still effective
More informationDiagnosis: Presenting signs and Symptoms include:
PERITONITIS TREATMENT PROTOCOL CARI - Caring for Australasians with Renal Impairment - CARI Guidelines complete list ISPD Guidelines: http://www.ispd.org/lang-en/treatmentguidelines/guidelines Objective
More informationChildrens Hospital Antibiogram for 2012 (Based on data from 2011)
Childrens Hospital Antibiogram for 2012 (Based on data from 2011) Prepared by: Department of Clinical Microbiology, Health Sciences Centre For further information contact: Andrew Walkty, MD, FRCPC Medical
More informationCefazolin vs. Antistaphyloccal Penicillins: The Great Debate
Cefazolin vs. Antistaphyloccal Penicillins: The Great Debate Annie Heble, PharmD PGY2 Pediatric Pharmacy Resident Children s Hospital Colorado Microbiology Rounds March 22, 2017 Image Source: Buck cartoons
More informationMANAGEMENT OF TOTAL JOINT ARTHROPLASTY INFECTIONS
MANAGEMENT OF TOTAL JOINT ARTHROPLASTY INFECTIONS Paul D. Holtom, MD Professor of Medicine and Orthopaedics USC Keck School of Medicine TOTAL JOINT ARTHROPLASTIES In 2009: 1 million THA and TKA By 2030,
More informationPathogens and Antibiotic Sensitivities in Post- Phacoemulsification Endophthalmitis, Kaiser Permanente, California,
Pathogens and Antibiotic Sensitivities in Post- Phacoemulsification Endophthalmitis, Kaiser Permanente, California, 2007-2012 Geraldine R. Slean, MD, MS 1 ; Neal H. Shorstein, MD 2 ; Liyan Liu, MD, MS
More informationPOTENTIAL STRUCTURE INDICATORS FOR EVALUATING ANTIMICROBIAL STEWARDSHIP PROGRAMMES IN EUROPEAN HOSPITALS
POTENTIAL STRUCTURE INDICATORS FOR EVALUATING ANTIMICROBIAL STEWARDSHIP PROGRAMMES IN EUROPEAN HOSPITALS Dirk VOGELAERS Department of General Internal Medicine, Infectious Diseases and Psychosomatic Medicine
More informationUCSF guideline for management of suspected hospital-acquired or ventilatoracquired pneumonia in adult patients
Background/methods: UCSF guideline for management of suspected hospital-acquired or ventilatoracquired pneumonia in adult patients This guideline establishes evidence-based consensus standards for management
More informationSuitability of Antibiotic Treatment for CAP (CAPTIME) The duration of antibiotic treatment in community acquired pneumonia (CAP)
STUDY PROTOCOL Suitability of Antibiotic Treatment for CAP (CAPTIME) Purpose The duration of antibiotic treatment in community acquired pneumonia (CAP) lasts about 9 10 days, and is determined empirically.
More informationMeasure Information Form
Release Notes: Measure Information Form Version 2.4 **NQF-NORS VOLUNTARY CONSNSUS STANARS FOR HOSPITAL CAR** Measure Information Form Measure Set: Surgical Care Improvement Project (SCIP) Set Measure I
More informationAppropriate Antimicrobial Therapy for Treatment of
Appropriate Antimicrobial Therapy for Treatment of Staphylococcus aureus infections ( MRSA ) By : A. Bojdi MD Assistant Professor Inf. Dis. Dep. Imam Reza Hosp. MUMS Antibiotics Still Miracle Drugs Paul
More informationScottish Medicines Consortium
Scottish Medicines Consortium daptomycin 350mg powder for concentrate for solution for infusion (Cubicin ) Chiron Corporation Limited No. (248/06) 10 March 2006 The Scottish Medicines Consortium (SMC)
More informationGive the Right Antibiotics in Trauma Mitchell J Daley, PharmD, BCPS
Give the Right Antibiotics in Trauma Mitchell J Daley, PharmD, BCPS Clinical Pharmacy Specialist, Critical Care Dell Seton Medical Center at the University of Texas and Seton Healthcare Family Clinical
More informationScottish Surveillance of Healthcare Infection Programme (SSHAIP) Health Protection Scotland SSI Surveillance Protocol 7th Edition 2017 Question &
Contents General... 4 Pre-op... 4 Peri-op... 5 Post-op... 8 Caesarean Section... 12 Orthopaedics... 14 Large Bowel:... 15 Vascular... 17 General Pre-op Q: If a patient is an emergency admission is the
More informationPrinciples of Anti-Microbial Therapy Assistant Professor Naza M. Ali. Lec 1
Principles of Anti-Microbial Therapy Assistant Professor Naza M. Ali Lec 1 28 Oct 2018 References Lippincott s IIIustrated Reviews / Pharmacology 6 th Edition Katzung and Trevor s Pharmacology / Examination
More informationTreatment of Surgical Site Infection Meeting Quality Statement 6. Prof Peter Wilson University College London Hospitals
Treatment of Surgical Site Infection Meeting Quality Statement 6 Prof Peter Wilson University College London Hospitals TEG Quality Standard 6 Treatment and effective antibiotic prescribing: People with
More informationSHC Surgical Antimicrobial Prophylaxis Guidelines
SHC Surgical Antimicrobial Prophylaxis Guidelines I. Purpose/Background This document is based upon the 2013 consensus guidelines from American Society of Health-System Pharmacists (ASHP), the Infectious
More informationIn an effort to help reduce surgical site infections, Surgical Services associates will be expected to observe the following guidelines:
To: Dept. of Surgery Associates From: Gloria Karr, Dir. Infection Prevention Date: May, 2012 Re: Guidelines for Infection Control in In an effort to help reduce surgical site infections, Surgical Services
More informationConsiderations in antimicrobial prescribing Perspective: drug resistance
Considerations in antimicrobial prescribing Perspective: drug resistance Hasan MM When one compares the challenges clinicians faced a decade ago in prescribing antimicrobial agents with those of today,
More information2019 COLLECTION TYPE: MIPS CLINICAL QUALITY MEASURES (CQMS) MEASURE TYPE: Process High Priority
Quality ID #407: Appropriate Treatment of Methicillin-Susceptible Staphylococcus Aureus (MSSA) Bacteremia National Quality Strategy Domain: Effective Clinical Care Meaningful Measure Area: Healthcare Associated
More informationLe infezioni di cute e tessuti molli
Le infezioni di cute e tessuti molli SCELTE e STRATEGIE TERAPEUTICHE Pierluigi Viale Clinica di Malattie Infettive Policlinico S. Orsola Malpighi Treatment of complicated skin and skin structure infections
More informationNorthwestern Medicine Central DuPage Hospital Antimicrobial Criteria Updated 11/16/16
Northwestern Medicine Central DuPage Hospital Antimicrobial Criteria Updated 11/16/16 These criteria are based on national and local susceptibility data as well as Infectious Disease Society of America
More informationCase 2 Synergy satellite event: Good morning pharmacists! Case studies on antimicrobial resistance
Case 2 Synergy satellite event: Good morning pharmacists! Case studies on antimicrobial resistance 22nd Congress of the EAHP "Hospital pharmacists catalysts for change", 22-24 March 2017, Cannes Disclosure
More informationNeurosurgery Antibiotic Prophylaxis Guideline
Neurosurgery Antibiotic Prophylaxis Guideline Full Title of Guideline: Author (include email and role): Division & Speciality: Scope (Target audience, state if Trust wide): Review date (when this version
More informationIs Cefazolin Inferior to Nafcillin for Treatment of Methicillin-Susceptible Staphylococcus aureus Bacteremia?
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, Nov. 2011, p. 5122 5126 Vol. 55, No. 11 0066-4804/11/$12.00 doi:10.1128/aac.00485-11 Copyright 2011, American Society for Microbiology. All Rights Reserved. Is Cefazolin
More informationAntimicrobial stewardship: Quick, don t just do something! Stand there!
Antimicrobial stewardship: Quick, don t just do something! Stand there! Stanley I. Martin, MD, FACP, FIDSA Director, Division of Infectious Diseases Director, Antimicrobial Stewardship Program Geisinger
More informationNational Antimicrobial Prescribing Survey
Indication documented Surgical prophylaxis >24 hrs Allergy mismatch Microbiology mismatch Incorrect route Incorrect dose/frequency Incorrect duration Therapeutic Guidelines Local guidelines * Non-compliant
More informationManagement of Native Valve
Management of Native Valve Infective Endocarditis 2005 AHA 2015 Baddour LM, et al. Circulation. 2015;132(15):1435-86 2009 ESC 2015 Habib G, et al. Eur Heart J. 2015;36(44):3075-128 ESC 2015: Endocarditis
More informationAntibiotic Usage Guidelines in Hospital
SUPPLEMENT TO JAPI december VOL. 58 51 Antibiotic Usage Guidelines in Hospital Camilla Rodrigues * Use of surveillance data information of Hospital antibiotic policy guidelines from Hinduja Hospital. The
More informationOPTIMIZATION OF PK/PD OF ANTIBIOTICS FOR RESISTANT GRAM-NEGATIVE ORGANISMS
HTIDE CONFERENCE 2018 OPTIMIZATION OF PK/PD OF ANTIBIOTICS FOR RESISTANT GRAM-NEGATIVE ORGANISMS FEDERICO PEA INSTITUTE OF CLINICAL PHARMACOLOGY DEPARTMENT OF MEDICINE, UNIVERSITY OF UDINE, ITALY SANTA
More informationIntroduction to Chemotherapeutic Agents. Munir Gharaibeh MD, PhD, MHPE School of Medicine, The university of Jordan November 2018
Introduction to Chemotherapeutic Agents Munir Gharaibeh MD, PhD, MHPE School of Medicine, The university of Jordan November 2018 Antimicrobial Agents Substances that kill bacteria without harming the host.
More informationAntimicrobial Pharmacodynamics
Antimicrobial Pharmacodynamics November 28, 2007 George P. Allen, Pharm.D. Assistant Professor, Pharmacy Practice OSU College of Pharmacy at OHSU Objectives Become familiar with PD parameters what they
More informationTrust Guideline for the Management of: Antibiotic Prophylaxis in adults undergoing procedures in Interventional Radiology
Antibiotic Prophylaxis in adults undergoing procedures in Interventional Radiology A Clinical Guideline For use in: By: For: Division responsible for document: Key words: Interventional Radiology Prescribers
More informationDepartment of Pharmacy Practice, N.E.T. Pharmacy College, Raichur , Karnataka, India
Bulletin of Pharmaceutical Research 2017;7(1):141 An Official Publication of Association of Pharmacy Professionals ISSN: 2249-6041 (Print); ISSN: 2249-9245 (Online) DOI: 10.21276/bpr.2017.7.1.4 RESEARCH
More informationThe β- Lactam Antibiotics. Munir Gharaibeh MD, PhD, MHPE School of Medicine, The University of Jordan November 2018
The β- Lactam Antibiotics Munir Gharaibeh MD, PhD, MHPE School of Medicine, The University of Jordan November 2018 Penicillins. Cephalosporins. Carbapenems. Monobactams. The β- Lactam Antibiotics 2 3 How
More informationReducing Infections in Surgical Practice. Fred A Sweet, MD Rockford Spine Center Illinois, USA
Reducing Infections in Surgical Practice Fred A Sweet, MD Rockford Spine Center Illinois, USA Introduction: How bacteria get in The Host The Surgeon The Procedure The STAFF Skin PREP Prophylactic Antibiotics
More informationAntimicrobial utilization: Capital Health Region, Alberta
ANTIMICROBIAL STEWARDSHIP Antimicrobial utilization: Capital Health Region, Alberta Regionalization of health care services in Alberta began in 1994. In the Capital Health region, restructuring of seven
More informationCHAPTER:1 THE RATIONAL USE OF ANTIBIOTICS. BY Mrs. K.SHAILAJA., M. PHARM., LECTURER DEPT OF PHARMACY PRACTICE, SRM COLLEGE OF PHARMACY
CHAPTER:1 THE RATIONAL USE OF ANTIBIOTICS BY Mrs. K.SHAILAJA., M. PHARM., LECTURER DEPT OF PHARMACY PRACTICE, SRM COLLEGE OF PHARMACY Antibiotics One of the most commonly used group of drugs In USA 23
More informationActive Bacterial Core Surveillance Site and Epidemiologic Classification, United States, 2005a. Copyright restrictions may apply.
Impact of routine surgical ward and intensive care unit admission surveillance cultures on hospital-wide nosocomial methicillin-resistant Staphylococcus aureus infections in a university hospital: an interrupted
More informationPharmacological Evaluation of Amikacin in Neonates
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, JUlY 1975, p. 86-90 Copyright 0 1975 American Society for Microbiology Vol. 8, No. 1 Printed in U.SA. Pharmacological Evaluation of Amikacin in Neonates JORGE B.
More information1) Mangram AJ,Horan TC,Pearson ML, et al:guideline for Prevention of Surgical Site Infection.Infect Control Hosp Epidemiol 1999;20:247-278. 1a) Perl TM, Cullen JJ, Wenzel RP, et al.: Intranasal mupirocin
More informationProphylactic antibiotics in penetrating abdominal trauma: Outcome data
Prophylactic antibiotics in trauma: Outcome data Author & Reference Title Class Antibiotics #Pts Duration (days) Organs injured The duration of Bozorgzedeh A antibiotic administration I cefoxitin 148 24
More informationASHP Therapeutic Guidelines on Antimicrobial Prophylaxis in Surgery
426 ASHP Therapeutic Guidelines ASHP Therapeutic Guidelines on Antimicrobial Prophylaxis in Surgery The ASHP Therapeutic Guidelines on Antimicrobial Prophylaxis in Surgery, 1 which have provided practitioners
More informationNo-leaching. No-resistance. No-toxicity. >99.999% Introducing BIOGUARD. Best-in-class dressings for your infection control program
Introducing BIOGUARD No-leaching. >99.999% No-resistance. No-toxicity. Just cost-efficient, broad-spectrum, rapid effectiveness you can rely on. Best-in-class dressings for your infection control program
More informationPharmacist Coordinated Antimicrobial Therapy: OPAT and Transitions of Care
Pharmacist Coordinated Antimicrobial Therapy: OPAT and Transitions of Care Jennifer McCann, PharmD, BCCCP State Director of Clinical Pharmacy Services St. Vincent Health Indiana Conflicts of Interest No
More informationMeasure Information Form
Release Notes: Measure Information Form Version 2.0 **NQF-NDORSD VOLUNTRY CONSNSUS STNDRDS FOR HOSPITL CR** Measure Information Form Measure Set: Surgical Care Improvement Project (SCIP) Set Measure ID
More informationPharmacokinetic & Pharmadynamic of Once Daily Aminoglycosides (ODA) and their Monitoring. Janis Chan Pharmacist, UCH 2008
Pharmacokinetic & Pharmadynamic of Once Daily Aminoglycosides (ODA) and their Monitoring Janis Chan Pharmacist, UCH 25-4-2008 2008 Aminoglycosides (AG) 1. Gentamicin 2. Amikacin 3. Streptomycin 4. Neomycin
More informationAn Evidence Based Approach to Antibiotic Prophylaxis in Oral Surgery
An Evidence Based Approach to Antibiotic Prophylaxis in Oral Surgery Nicholas Makhoul DMD. MD. FRCD(C). Dip ABOMS. FACS. Director, Division of Oral and Maxillofacial Surgery Assistant Professor McGill
More informationIncidence of hospital-acquired Clostridium difficile infection in patients at risk
Baptist Health South Florida Scholarly Commons @ Baptist Health South Florida All Publications 5-20-2016 Incidence of hospital-acquired Clostridium difficile infection in patients at risk Christine Ibarra
More informationMCW & FMLH Antibiotic Guide. Suggested Recommendations and Guidelines for Surgical Prophylaxis
MCW & FMLH Antibiotic Guide This guide was prepared by members of the Antibiotic Subcommittee of the Pharmacy and Therapeutics Committee and has been approved for use at Froedtert Hospital. Suggested Recommendations
More informationSepsis is the most common cause of death in
ADDRESSING ANTIMICROBIAL RESISTANCE IN THE INTENSIVE CARE UNIT * John P. Quinn, MD ABSTRACT Two of the more common strategies for optimizing antimicrobial therapy in the intensive care unit (ICU) are antibiotic
More informationThe Choice. V e r s a t i l i t y. S t r e n g t h. F l e x i b i l i t y. of surgeons for half a century
The Choice of surgeons for half a century V e r s a t i l i t y S t r e n g t h F l e x i b i l i t y S t o p b l e e d i n g f a s t w i t h t h r e e p r o v e n p e r f o r m e r s SURGICEL Absorbable
More informationApproach to pediatric Antibiotics
Approach to pediatric Antibiotics Gassem Gohal FAAP FRCPC Assistant professor of Pediatrics objectives To be familiar with common pediatric antibiotics o Classification o Action o Adverse effect To discus
More informationSurveillance of Antimicrobial Resistance and Healthcare-associated Infections in Europe
Surveillance of Antimicrobial Resistance and Healthcare-associated Infections in Europe Carl Suetens, ECDC Presented by Håkan Hanberger ecdc.europa.eu Message/Questions from C Suetens to Workshop 7, MIE2009
More informationBarriers to Intravenous Penicillin Use for Treatment of Nonmeningitis
JCM Accepts, published online ahead of print on 7 July 2010 J. Clin. Microbiol. doi:10.1128/jcm.01012-10 Copyright 2010, American Society for Microbiology and/or the Listed Authors/Institutions. All Rights
More informationInt.J.Curr.Microbiol.App.Sci (2017) 6(3):
International Journal of Current Microbiology and Applied Sciences ISSN: 2319-7706 Volume 6 Number 3 (2017) pp. 891-895 Journal homepage: http://www.ijcmas.com Original Research Article https://doi.org/10.20546/ijcmas.2017.603.104
More informationInternational Journal of Research in Pharmacology & Pharmacotherapeutics
International Journal of Research in Pharmacology & Pharmacotherapeutics ISSN Print: 2278 2648 IJRPP Vol.3 Issue 3 July-Sep-214 ISSN Online: 2278-2656 Journal Home page: Research article Open Access Study
More informationResponders as percent of overall members in each category: Practice: Adult 490 (49% of 1009 members) 57 (54% of 106 members)
Infectious Diseases Society of America Emerging Infections Network 6/2/10 Report for Query: Perioperative Staphylococcus aureus Screening and Decolonization Overall response rate: 674/1339 (50.3%) physicians
More informationSurgical Site Infections (SSIs)
Surgical Site Infections (SSIs) Postoperative infections presenting at any level Incisional superficial (skin, subcutaneous tissue) Incisional deep (fascial plane and muscles) Organ/space related (anatomic
More informationMeasure Information Form
Release Notes: Measure Information Form Version 2.0 **NQF-ENDORSED VOUNTRY CONSENSUS STNDRDS FOR HOSPIT CRE** Measure Information Form Measure Set: Surgical Care Improvement Project (SCIP) Set Measure
More informationDATA COLLECTION SECTION BY FRONTLINE TEAM. Patient Identifier/ Medical Record number (for facility use only)
Assessment of Appropriateness of ICU Antibiotics (Patient Level Sheet) **Note this is intended for internal purposes only. Please do not return to PQC.** For this assessment, inappropriate antibiotic use
More informationAmerican Association of Feline Practitioners American Animal Hospital Association
American Association of Feline Practitioners American Animal Hospital Association Basic Guidelines of Judicious Therapeutic Use of Antimicrobials August 1, 2006 Introduction The Basic Guidelines to Judicious
More information